GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,031,000 | +1044.6% | 250,091 | +437.1% | 0.37% | +843.6% |
| Q2 2022 | $1,488,000 | +229.9% | 46,563 | +257.4% | 0.04% | +254.5% |
| Q1 2022 | $451,000 | -73.4% | 13,027 | -77.5% | 0.01% | -60.7% |
| Q4 2021 | $1,696,000 | -24.7% | 57,946 | -34.4% | 0.03% | -24.3% |
| Q3 2021 | $2,251,000 | +678.9% | 88,336 | +1374.7% | 0.04% | +311.1% |
| Q1 2018 | $289,000 | -14.2% | 5,990 | -30.1% | 0.01% | 0.0% |
| Q4 2017 | $337,000 | +15.4% | 8,565 | -8.8% | 0.01% | +28.6% |
| Q3 2017 | $292,000 | -50.8% | 9,390 | -56.7% | 0.01% | -61.1% |
| Q2 2017 | $594,000 | +36.6% | 21,705 | -17.3% | 0.02% | +100.0% |
| Q2 2016 | $435,000 | +25.7% | 26,243 | +220.0% | 0.01% | -25.0% |
| Q3 2015 | $346,000 | – | 8,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |